Changes in endothelium-derived vascular regulatory factors during dobutamine-stress-induced silent myocardial ischemia in patients with Kawasaki disease

Japanese Circulation Journal

Volumn 63, Issue 7, 1999, Pages 503-508

  Hino, Yoshiaki ^a   Ohkubo, Takashi ^a   Katsube, Yasuhiro ^a   Ogawa, Shunichi ^a  

^a NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

Author keywords

Coronary circulation; Ischemic myocardium; Kawasaki disease; Vasoactive substances

Indexed keywords

DOBUTAMINE; ENDOTHELIN 1; LACTIC ACID; PROSTAGLANDIN F1 ALPHA; THROMBOXANE B2;

ARTICLE; BLOOD FLOW VELOCITY; CHILD; CLINICAL ARTICLE; CORONARY ARTERY CONSTRICTION; CORONARY HEMODYNAMICS; DISEASE ASSOCIATION; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOPHYSIOLOGY; PROSTAGLANDIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; VASCULAR ENDOTHELIUM; VASOSPASM;

ADOLESCENT; CALCINOSIS; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; CORONARY ANGIOGRAPHY; DOBUTAMINE; ENDOTHELIN-1; ENDOTHELINS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFANT; LACTIC ACID; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIAL ISCHEMIA; NITRATES; NITRIC OXIDE; PROSTAGLANDINS F; REST; STRESS; THROMBOXANE B2;

EID: 0032792618     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.503     Document Type: Article

References (41)

1. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376
2. Luscher TF, Vanhoutte PM: The endothelium: Modulator of cardiovascular function. Boca Raton, FL: CRC Pres Inc, 1990
3. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415
4. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
5. Vanhoutte PM: Other endothelium-derived relaxing factors. Circulation 1993; 87(Suppl V): V9-V17
6. Tada M, Kuzuya T, Inoue M, Kodama K, Mishima M, Yamada M, et al: Elevation of thromboxane B2 levels in patients with classic and variant angina pectoris. Circulation 1981; 64: 1107-1115
7. Toyo-oka T, Aizawa T, Suzuki N, Hirata Y, Miyauchi T, Shin WS, et al: Increased plasma level of endothelin-I and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 1991; 83: 476-483
8. Fujiwara T, Fujiwara H, Nakano H: Pathological features of coronary arteries in children with Kawasaki disease in which coronary arterial aneurysm was absent at autopsy: Quantitative analysis. Circulation 1988; 78: 345-350
9. Verani MS, Mahmarian JJ: Pharmacological stress nuclear cardiology imaging. Am J Card Imaging 1994; 8: 223-230
10. Bahl VK, Vasan RS, Malhotra A, Wasir HS: A comparison of dobutamine infusion and exercise during radionuclide ventriculography in the evaluation of coronary arterial disease. Int J Cardiol 1992; 35: 49-55
11. Bahl VK, Chandra S, Malhotra A, Wasir HS: Comparison of dobutamine infusion and exercise during radionuclide ventriculography in the risk stratification after acute myocardial infarction. Int J Cardiol 1994; 44: 235-241
12. Gnalp B, Uyan C, Dokumaci B, ÷zg, ven M, Vardareli E, ÷z,rk E, et al: Dobutamine stress radionuclide ventriculography for the detection of coronary artery disease. Nucl Med Commun 1993; 14: 471-478
13. Herman SD, LaBresh KA, Santos-Ocampo CD, Garber CE, Barbour MM, Messinger DE, et al: Comparison of dobutamine and exercise using Technetium-99m sestamibi imaging for the evaluation of coronary artery disease. Am J Cardiol 1994; 73: 164-169
14. Freeman ML, Palac R, Mason J, Barnes WE, Eastman G, Virupannavar S. et al: A comparison of dobutamine infusion and supine bicycle exercise for radionuclide cardiac stress testing. Clin Nucl Med 1984; 9: 251-255
15. Pennell DJ, Underwood SR, Swanton RH: Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol 1991; 18: 1471-1479
16. Leppo JA: Dipyridamole-thallium imaging: The lazy man's stress test. J Nucl Med 1989; 30: 281-287
17. Nguyen T, Heo J, Ogiby JD, Iskandrian AS: Single-photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: Correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography. J Am Coll Cardiol 1990; 16: 1375-1383
18. Pennell DJ, Underwood SR, Ell PJ: Safety of dobutamine stress for Thallium-201 myocardial perfusion tomography in patients with asthma. Am J Cardiol 1993; 71: 1346-1350
19. Mason JR, Palac RT, Freeman ML, Virupannavar S, Loeb HS, Kaplan E, et al: Thallium scintigraphy during dobutamine infusion: Nonexercise-dependent screening test for coronary artery disease. Am Heart J 1984; 107: 481-485
20. Previtali M, Lanzarini L, Ferrario M, Tortorici M, Mussini A, Montemartini C: Dobutamine vs. dipyridamole echocardiography in coronary artery disease. Circulation 1991; 83(Suppl III): 27-31
21. Chilian WM, Layne SM, Eastham CL, Marcus M: Heterogeneous microvascular coronary a-adrenergic vasoconstriction. Circ Res 1989; 64: 376-388
22. Warltier DC, Gross GJ, Brooks HL: Pharmacologic vs. ischemia-induced coronary artery vasoconstriction. Am J Physiol 1981; 240: H767-H774
23. Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 9797-9800
24. Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y: Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988; 238: 249-252
25. Ignarro LJ: Nitric oxide: A novel signal transaction mechanism for transcellular communication. Hypertension 1990; 16: 477-483
26. Dinerman JL, Lowenstein CJ, Snyder S.H: Molecular mechanisms of nitric oxide regulation: Potential relevance to cardiovascular disease. Circ Res 1993; 73: 217-222
27. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012
28. Koide M, Kawahara Y, Tsuda T: Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett 1993; 318: 213-217
29. Hansson GK, Geng Y, Holm J, Hardhammar P, Wennmalm A, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med 1994; 180: 733-738
30. Park HA, Rubin LE, Gross RS, Levi R: Nitric oxide is a mediator of hypoxic coronary vasodilation. Circ Res 1992; 71: 992-1001
31. Miloslav M, Schrader J: Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res 1992; 70: 208-212
32. Balligand JL, Ungureanu D, Kell RA, Kobzik L, Pimental D, Michel T: Abnormal contractile function due to induction of nitric oxide synthesis in rat myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 1993; 91: 2314-2319
33. Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Tada M: Plasma nitric oxide and products are increased in the ischemic canine heart. Biochem Biophys Res Commun 1995; 211: 370-374
34. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM: Nitric oxide activity in the human coronary circulation. J Clin Invest 1995; 95: 1747-1755
35. Egashira K, Hirooka Y, Kuga T, Mohri M, Takeshita A: Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation induced by acetylcholine in patients with angina and normal coronary arteriograms. Circulation 1996; 94: 130-134
36. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348: 730-732
37. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K: Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature 1990; 348: 732-735
38. Hirata M, Hayashi Y, Ushikubi F, Yokota Y, Kageyama R, Nakanishi S: Cloning and expression of cDNAS for a human thromboxane A2 receptor. Nature 1991; 349: 617-620
39. Nakagawa O, Tanaka I, Usui T, Harada M, Sasaki Y, Itoh H: Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system. Circulation 1994; 90: 1643-1647
40. Sugimoto T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N: Vasodilatory response of the coronary arteries after Kawasaki disease: Evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr 1992; 121: 684-688
41. Ino T, Shimazaki S, Akimoto K, Park I, Nishimoto K, Yabuta K, et al: Coronary artery calcification in Kawasaki disease. Pediatr Rodiol 1990; 20: 520-523